The TB Fast Track trial assessed an algorithm using body mass index, presence of anaemia and urine TB-LAM testing to identify HIV-positive ambulatory patients with CD4 cell counts ≤150 cells/μL at high risk of TB in whom empirical TB treatment was started immediately, but found no reduction in 6-month mortality compared to the standard of care [34, 35]. This evidence concerns the gene CD4 and anemia.